Assessment of Morbidity and Mortality Following Serratus Anterior Plane Block (SAPB) for Unilateral Rib Fractures

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The goal of this observational study is to learn about the long-term effects of the serratus anterior plane block (SAPB) in adult patients who suffered multiple unilateral anterolateral rib fractures within 24 hours of patient presentation to the emergency department. The main question it aims to answer is: Does the SAPB for multiple anterolateral rib fractures demonstrate reduction in patient morbidity and mortality, including incidence of pneumonia, length of hospital stay, discharge disposition, and death, as compared to standard analgesic regimens. The SAPB will be performed if a physician trained in the SAPB is available within 24 hours of injury. If a trained physician is not available and the patient meets inclusion criteria, they will receive parental analgesia with opioid therapy. They will be followed until date of hospital discharge, up until 60 days.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients over 18 years of age being treated in the Emergency Department at Jacobi Medical Center

• Presenting within 24 hours of injury

• Patient with 2 or more unilateral, anterior or lateral rib fractures

• Able to provide consent (patient or health care proxy)

• Clinical team believes the patient will require inpatient admission at the time of enrollment

Locations
United States
New York
Jacobi Medical Center
RECRUITING
The Bronx
Contact Information
Primary
Ariella Gartenberg, MD
ariella.applebaum@gmail.com
2017871762
Backup
Michelle Montenegro, MD
michelle.a.montenegro@gmail.com
7189185800
Time Frame
Start Date: 2025-08-10
Estimated Completion Date: 2026-08
Participants
Target number of participants: 220
Treatments
Serratus Anterior Plane Block (SAPB)
Following visualization of the serratus anterior muscle, the latissimus dorsi muscle, and the pleural line, and creating a skin wheel at the puncture site, a 22-gauge 3.5 or 4 inch echogenic PAJUNK® SonoBlock II needle will be inserted just lateral to the transducer at 45 degrees. The needle will be visualized in-plane under real time ultrasound guidance to ensure correct placement between the latissimus dorsi and serratus anterior muscle. 20 ml of bupivacaine hydrochloride 0.25% will be infiltrated into the superficial plane and local anesthetic spread will be observed on ultrasound. Ultrasound images will be obtained pre-procedure, during, and post procedure to demonstrate that the needle tip is away from the pleura and appropriate hydrodissection of muscle fascia occurs.
Non-SAPB
Patients in this arm will receive IV analgesia, mainly opioid therapy.
Related Therapeutic Areas
Sponsors
Leads: Albert Einstein College of Medicine
Collaborators: Jacobi Medical Center

This content was sourced from clinicaltrials.gov